Literature DB >> 15760452

Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4.

Philipp M Lepper1, Martha Triantafilou, Christian Schumann, E Marion Schneider, Kathy Triantafilou.   

Abstract

Infection with Helicobacter pylori, a Gram-negative bacterium, is strongly associated with gastric ulcers and adenocarcinoma. The mechanisms by which the innate immune system recognizes H. pylori lipopolysaccharide (LPS) remain unclear. Contradictory reports exist that suggest that Toll-like receptors are involved. In this study we evaluated the interactions of Toll-like receptors with LPS from different strains of H. pylori. Using reporter cell lines, as well as HEK293 cells transfected with either CD14 and TLR4, or CD14 and TLR2, we show that H. pylori LPS-induced cell activation is mediated through TLR2. In addition, for the first time, we report that LPS from some H. pylori strains are able to antagonize TLR4. The antagonistic activity of H. pylori LPS from certain strains, as well as the activation via TLR2, might give H. pylori an advantage over the host that may be associated with the clinical outcome of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760452     DOI: 10.1111/j.1462-5822.2005.00482.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  37 in total

1.  Differential host response to LPS variants in amniochorion and the TLR4/MD-2 system in Macaca nemestrina.

Authors:  J Chang; S Jain; D J Carl; L Paolella; R P Darveau; M G Gravett; K M Adams Waldorf
Journal:  Placenta       Date:  2010-09       Impact factor: 3.481

2.  Synthesis and characterization of a dipalmitoylated lipopeptide derived from paralogous lipoproteins of Mycoplasma pneumoniae.

Authors:  Takeshi Into; Jun-ichi Dohkan; Megumi Inomata; Misako Nakashima; Ken-ichiro Shibata; Kenji Matsushita
Journal:  Infect Immun       Date:  2007-02-26       Impact factor: 3.441

3.  Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Subbulaxmi Trikudanathan; Alla L Zozulya; Carolina Sandoval-Garcia; Jennifer K Kennedy; Olga Atochina; Thomas Norberg; Bastien Castagner; Peter Seeberger; Zsuzsa Fabry; Donald Harn; Samia J Khoury; Indira Guleria
Journal:  Clin Immunol       Date:  2011-12-30       Impact factor: 3.969

Review 4.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 5.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 6.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

7.  Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling.

Authors:  Irina N Baranova; Roger Kurlander; Alexander V Bocharov; Tatyana G Vishnyakova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Implications for a role of interleukin-23 in the pathogenesis of chronic gastritis and of peptic ulcer disease.

Authors:  V Koussoulas; S Vassiliou; E J Giamarellos-Bourboulis; G Tassias; A Kotsaki; C Barbatzas; M Tzivras
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

9.  Helicobacter pylori impairs murine dendritic cell responses to infection.

Authors:  Ya-Hui Wang; Jean-Pierre Gorvel; Yen-Ting Chu; Jiunn-Jong Wu; Huan-Yao Lei
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

10.  Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.

Authors:  Yang Wang; Akram A Da'Dara; Paul G Thomas; Donald A Harn
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.